PABIR1 and neoplasm: cBioPortal34 highlighted that FAM122A R105L, V107G variants are present in different cancers (FAM122A is a tumour suppressor, as patients with cancer who express low levels of FAM122A have significantly worse overall survival than those with high levels of expression8).